Prot# 001.1035: Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype With Local GM-CSF in First Complete Remission (also know as #00-C-0050 NCI Protocol #92) (and NCI 9900)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/11/00 → 1/1/11

Funding

  • Immunex Corporation (1.1035)